Application | Comment | Organism |
---|---|---|
medicine | both PON1 bioavailability and catalytic activity are decreased in children with autism spectrum disorders | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood plasma | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.611 | - |
using paraoxin as substrate (paraoxonase activity of PON1), at 25°C | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
paraoxon + H2O | - |
Homo sapiens | diethylphosphate + 4-nitrophenol | - |
? |
Synonyms | Comment | Organism |
---|---|---|
HDL-associated esterase/lactonase paraoxonase 1 | - |
Homo sapiens |
high-density lipoprotein-associated esterase/lactonase | - |
Homo sapiens |
paraoxonase | - |
Homo sapiens |
paraoxonase 1 | - |
Homo sapiens |
PO.ase | - |
Homo sapiens |
PON1 | catalyses the hydrolysis of arylesters, toxic organophosphate compounds, carbamates and lactones, shows higher arylesterase than paraoxonase activity | Homo sapiens |